Ocugen Inc (OCGN)
$0.86 -$0.00 (-0.33%) 4:38 PM 12/13/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$253.45M -
Day's Range
$0.82 - $0.88 -
Volume
3,778,769 -
52 Week Low / High
$0.36 - $2.10 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 2
- Strong Buy
- 2
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $4.00
- Target Price
Company News
-
State Street Corp's Strategic Acquisition of Shares in Ocugen Inc — Oct 16th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 1,047,896 shares of Ocugen Inc (NASDAQ:OCGN), a biotechnology firm based in the USA. This transaction increased State Street Corp's total holdin...
-
State Street Corp's Strategic Acquisition of Shares in Ocugen Inc — Oct 16th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 1,047,896 shares of Ocugen Inc (NASDAQ:OCGN), a biotechnology firm based in the USA. This transaction increased State Street Corp's total holdin...
-
State Street Corp's Strategic Acquisition of Shares in Ocugen Inc — Oct 16th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 1,047,896 shares of Ocugen Inc (NASDAQ:OCGN), a biotechnology firm based in the USA. This transaction increased State Street Corp's total holdin...
-
State Street Corp's Strategic Acquisition of Shares in Ocugen Inc — Oct 16th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 1,047,896 shares of Ocugen Inc (NASDAQ:OCGN), a biotechnology firm based in the USA. This transaction increased State Street Corp's total holdin...
-
State Street Corp's Strategic Acquisition of Shares in Ocugen Inc — Oct 16th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 1,047,896 shares of Ocugen Inc (NASDAQ:OCGN), a biotechnology firm based in the USA. This transaction increased State Street Corp's total holdin...
-
State Street Corp's Strategic Acquisition of Shares in Ocugen Inc — Oct 16th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 1,047,896 shares of Ocugen Inc (NASDAQ:OCGN), a biotechnology firm based in the USA. This transaction increased State Street Corp's total holdin...
-
State Street Corp's Strategic Acquisition of Shares in Ocugen Inc — Oct 16th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 1,047,896 shares of Ocugen Inc (NASDAQ:OCGN), a biotechnology firm based in the USA. This transaction increased State Street Corp's total holdin...
-
State Street Corp's Strategic Acquisition of Shares in Ocugen Inc — Oct 16th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 1,047,896 shares of Ocugen Inc (NASDAQ:OCGN), a biotechnology firm based in the USA. This transaction increased State Street Corp's total holdin...
-
1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid — Jul 11th, 2024
It hasn't been a stellar year so far for biotech companies. The industry, as measured by the SPDR S&P Biotech ETF, is up just 4% since January, significantly lagging the S&P 500 's nearly 17% gain. Of course, it's not hard to find stocks that have performed both better and worse than the ...
Portfolio
Comprised of 1 portfolios